<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Allergic disease is a key public health problem that has increased rapidly in recent decades in both developed and developing countries, and it is now recognized as a major global epidemic (
 <xref rid="r22" ref-type="bibr" class="xref">Pawankar 2014</xref>; 
 <xref rid="r23" ref-type="bibr" class="xref">Platts-Mills 2015</xref>). The economic burden of allergic disease is considerable. In 2007, the total cost of allergic disease to the United States was 19.7 billion USD, and estimates for the European Union range from 55 to 151 billion EUR (
 <xref rid="r34" ref-type="bibr" class="xref">Zuberbier et al. 2014</xref>). In terms of specific allergic diseases, the World Health Organization (WHO) estimates that 400 million people in the world suffer from allergic rhinitis and 300 million from asthma (
 <xref rid="r6" ref-type="bibr" class="xref">Bousquet and Khaltaev 2007</xref>). Within Europe, the prevalence of pollen allergy in the general population is estimated at 40% (
 <xref rid="r13" ref-type="bibr" class="xref">Dâ€™Amato et al. 2007</xref>).
</p>
